Search

everythinglearnresearchcommunity

for

Search:↓

Patients with deficiency syndrome, especially qi deficiency, have a higher risk of type 2 heart attacks.

New-onset fibromyalgia after COVID-19 is poorly understood and needs more research.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

Minoxidil can improve hair growth in some patients with woolly hair due to LIPH variants, with varying responses and mild side effects.

Probiotics show promise for health benefits but need more research to understand how they work.

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.

SARS-CoV-2 proteins help the virus avoid the immune system, delaying response and increasing inflammation.

SVF may improve nanofat treatment for acne scars, but more research is needed.

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

Myhre syndrome symptoms worsen over time, with specific genetic variants affecting severity.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

Most COVID-19 patients had lingering symptoms 60 days after leaving the hospital.

Some recovered COVID-19 patients experience skin, hair, and nail issues, suggesting they need follow-up care.

We need safe, affordable drugs to fight coronaviruses effectively.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Interest in long-COVID symptoms in Japan increased with COVID-19 case peaks, especially for hair loss, cough, smell/taste issues, and headache.

18% of COVID-19 survivors experience PTSD, with risk factors including age, gender, smoking, and lung damage.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Methotrexate effectively controls eye inflammation in Japanese patients with non-infectious uveitis but requires careful monitoring for side effects.

MRSA infections can occur in hair transplant surgeries, so it's important to test for it before treatment, keep everything clean, and follow treatment based on test results.

Thrombophilic conditions may worsen Long COVID symptoms due to increased blood clotting.

Long-term effects of COVID-19 can vary over time and are more likely in certain age and gender groups, while race, income, and education levels have little to no impact. Ongoing medical care is needed due to potential complications.

Long COVID causes lasting symptoms and needs ongoing care.

Nanoparticles may improve treatment for lung disease by targeting cells better and reducing side effects.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

The gel shows strong potential for effectively treating pressure ulcers.

Stopping antifungal prophylaxis after 1 year may be safe for low-risk transplant patients.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

A calf in Scotland likely had Schmallenberg virus from its mother.